Byrnes AP[au] - Search Results

Year	Number of Results
1992	1
1994	3
1995	1
1996	4
1997	2
1998	5
1999	1
2000	3
2004	3
2005	3
2006	3
2007	1
2008	4
2009	2
2010	1
2011	2
2013	2
2014	1
2015	1
2016	1
2017	1
2018	1
2019	1
2022	1
2024	0

1

Interaction of adenovirus with antibodies, complement, and coagulation factors.

Allen RJ, Byrnes AP. Allen RJ, et al. Among authors: byrnes ap. FEBS Lett. 2019 Dec;593(24):3449-3460. doi: 10.1002/1873-3468.13649. Epub 2019 Nov 15. FEBS Lett. 2019. PMID: 31660588 Free article. Review.

2

Emergence and virulence of encephalitogenic arboviruses.

Griffin DE, Byrnes AP, Cook SH. Griffin DE, et al. Among authors: byrnes ap. Arch Virol Suppl. 2004;(18):21-33. doi: 10.1007/978-3-7091-0572-6_3. Arch Virol Suppl. 2004. PMID: 15119760 Review.

3

Clearance of adenovirus by Kupffer cells is mediated by scavenger receptors, natural antibodies, and complement.

Xu Z, Tian J, Smith JS, Byrnes AP. Xu Z, et al. Among authors: byrnes ap. J Virol. 2008 Dec;82(23):11705-13. doi: 10.1128/JVI.01320-08. Epub 2008 Sep 24. J Virol. 2008. PMID: 18815305 Free PMC article.

4

Immune responses to adenovirus vectors in the nervous system.

Wood MJ, Charlton HM, Wood KJ, Kajiwara K, Byrnes AP. Wood MJ, et al. Among authors: byrnes ap. Trends Neurosci. 1996 Nov;19(11):497-501. doi: 10.1016/S0166-2236(96)10060-6. Trends Neurosci. 1996. PMID: 8931276 Review.

5

Binding of adenovirus species C hexon to prothrombin and the influence of hexon on vector properties in vitro and in vivo.

Tian J, Xu Z, Moitra R, Palmer DJ, Ng P, Byrnes AP. Tian J, et al. Among authors: byrnes ap. PLoS Pathog. 2022 Sep 26;18(9):e1010859. doi: 10.1371/journal.ppat.1010859. eCollection 2022 Sep. PLoS Pathog. 2022. PMID: 36156097 Free PMC article.

6

Evaluating the Impact of Natural IgM on Adenovirus Type 5 Gene Therapy Vectors.

Xu Z, Tian J, Harmon AW, Byrnes AP. Xu Z, et al. Among authors: byrnes ap. Methods Mol Biol. 2017;1643:187-196. doi: 10.1007/978-1-4939-7180-0_15. Methods Mol Biol. 2017. PMID: 28667539

7

Heparin-binding and patterns of virulence for two recombinant strains of Sindbis virus.

Bear JS, Byrnes AP, Griffin DE. Bear JS, et al. Among authors: byrnes ap. Virology. 2006 Mar 30;347(1):183-90. doi: 10.1016/j.virol.2005.11.034. Epub 2005 Dec 27. Virology. 2006. PMID: 16380143 Free article.

8

Circulating antibodies and macrophages as modulators of adenovirus pharmacology.

Khare R, Hillestad ML, Xu Z, Byrnes AP, Barry MA. Khare R, et al. Among authors: byrnes ap. J Virol. 2013 Apr;87(7):3678-86. doi: 10.1128/JVI.01392-12. Epub 2013 Jan 16. J Virol. 2013. PMID: 23325678 Free PMC article.

9

Impact of natural IgM concentration on gene therapy with adenovirus type 5 vectors.

Qiu Q, Xu Z, Tian J, Moitra R, Gunti S, Notkins AL, Byrnes AP. Qiu Q, et al. Among authors: byrnes ap. J Virol. 2015 Mar;89(6):3412-6. doi: 10.1128/JVI.03217-14. Epub 2014 Dec 31. J Virol. 2015. PMID: 25552715 Free PMC article.

10

Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement.

Xu Z, Qiu Q, Tian J, Smith JS, Conenello GM, Morita T, Byrnes AP. Xu Z, et al. Among authors: byrnes ap. Nat Med. 2013 Apr;19(4):452-7. doi: 10.1038/nm.3107. Epub 2013 Mar 24. Nat Med. 2013. PMID: 23524342

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

43 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year